Management of Treatment-Experienced HIV-Infected Patients

  • Author: Eric S. Daar, MD (More Info)
  • Section Editor: Eric S. Daar, MD
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 8/1/18 (What's New)

Summary

  • After assuring adherence and lack of drug–drug and drug–food interactions, it is important to assess whether the person has a fully active boosted PI available
  • For those without a fully active boosted PI, genotypic scores and phenotypic clinical cutoffs have been established for many agents in long-standing drug classes to predict level of drug activity, including newer agents within these classes
  • Agents from new drug classes such as entry inhibitors, post-attachment inhibitors, and INSTIs are assumed to be fully active in those who are naive to them[Lalezari 2003; Steigbigel 2008]
  • Selecting Among Available Antiretrovirals

    Action required